Sonia Weigle | SVP, IR, HR, and Corporate Affairs |
Scott Braunstein | Chairman and CEO |
Christy Shafer | CCO |
Joseph Hulihan | CMO |
Steven E. Pfanstiel | CFO and COO |
Brian Abrahams | RBC Capital Markets |
Joseph Thome | TD Cowen |
Andrew Tsai | Jefferies |
Charles Duncan | Cantor Fitzgerald |
Joon Lee | Truist Securities |
Marc Goodman | Leerink Partners |
Douglas Tsao | H.C. Wainwright |
Jay Olson | Oppenheimer |
Greetings and welcome to the Marinus Pharmaceuticals’ Second Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. And now it is my pleasure to introduce you to your host, Sonya Weigle, Senior Vice President Investor Relations, Human Resources, and Corporate Affairs.